US5795737A
(en)
*
|
1994-09-19 |
1998-08-18 |
The General Hospital Corporation |
High level expression of proteins
|
US5625048A
(en)
*
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
US5777079A
(en)
*
|
1994-11-10 |
1998-07-07 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
DE69618350T2
(de)
*
|
1995-01-31 |
2002-09-19 |
Bioimage As Soeborg |
Ein verfahren zum nachweis biologisch aktiver substanzen
|
EP1143011B1
(de)
*
|
1995-01-31 |
2005-10-26 |
BioImage A/S |
Verfahren zum Nachweis von biologisch aktiven Substanzen
|
US5958713A
(en)
|
1995-01-31 |
1999-09-28 |
Novo Nordisk A/S |
Method of detecting biologically active substances by using green fluorescent protein
|
GB9504446D0
(en)
*
|
1995-03-06 |
1995-04-26 |
Medical Res Council |
Improvements in or relating to gene expression
|
DE69604298T2
(de)
|
1995-09-22 |
2000-05-18 |
Bioimage A S Soeborg |
Varianten des grünen fluoreszenzproteins, gfp
|
AU1283497A
(en)
|
1995-12-08 |
1997-06-27 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Method and compositions for monitoring dna binding molecules in living cells
|
US5874304A
(en)
*
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
US6900304B2
(en)
|
1996-01-31 |
2005-05-31 |
The Regents Of The University Of California |
Emission ratiometric indicators of phosphorylation
|
US6803188B1
(en)
|
1996-01-31 |
2004-10-12 |
The Regents Of The University Of California |
Tandem fluorescent protein constructs
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
CA2250966A1
(en)
*
|
1996-04-19 |
1997-10-30 |
Mycogen Plant Science, Inc. |
Monitoring of transgenic plants with in vivo markers
|
AR006928A1
(es)
|
1996-05-01 |
1999-09-29 |
Pioneer Hi Bred Int |
Una molecula de adn aislada que codifica una proteina fluorescente verde como marcador rastreable para la transformacion de plantas, un metodo para laproduccion de plantas transgenicas, un vector de expresion, una planta transgenica y celulas de dichas plantas.
|
US6096865A
(en)
*
|
1996-05-06 |
2000-08-01 |
Amgen Inc. |
Mutants of the green fluorescent protein having improved fluorescent properties at 37°
|
US6027881A
(en)
*
|
1996-05-08 |
2000-02-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
|
US5989835A
(en)
*
|
1997-02-27 |
1999-11-23 |
Cellomics, Inc. |
System for cell-based screening
|
US5876711A
(en)
*
|
1996-05-31 |
1999-03-02 |
Onyx Pharmaceuticals, Inc. |
Methods and compositions for determining the tumor suppressor status of cells
|
US5925558A
(en)
*
|
1996-07-16 |
1999-07-20 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent protein substrates
|
US5912137A
(en)
*
|
1996-07-16 |
1999-06-15 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
US6593135B2
(en)
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
WO1998021355A1
(en)
|
1996-11-15 |
1998-05-22 |
Life Technologies, Inc. |
Mutants of green fluorescent protein
|
US6245564B1
(en)
*
|
1997-01-23 |
2001-06-12 |
Cornell Research Foundation, Inc. |
Method for separating cells
|
US6727071B1
(en)
|
1997-02-27 |
2004-04-27 |
Cellomics, Inc. |
System for cell-based screening
|
US7117098B1
(en)
|
1997-02-27 |
2006-10-03 |
Cellomics, Inc. |
Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
|
JP3683591B2
(ja)
|
1997-02-27 |
2005-08-17 |
セロミックス インコーポレイテッド |
細胞に基づくスクリーニングシステム
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
US5998204A
(en)
*
|
1997-03-14 |
1999-12-07 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
GB9706414D0
(en)
|
1997-03-27 |
1997-05-14 |
Univ Manchester |
Detection of DNA damage
|
US6342345B1
(en)
|
1997-04-02 |
2002-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by reporter subunit complementation
|
DE69837118T2
(de)
|
1997-04-07 |
2007-12-27 |
Fisher Biolmage Aps |
Ein Verfahren zum Screenen von Substanzen hinsichtlich ihres Effekts auf cAMP Spiegel basierend auf intrazellulärer Translokation von PKA
|
US6046925A
(en)
*
|
1997-04-14 |
2000-04-04 |
The Regents Of The University Of California |
Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins
|
DE19715683C2
(de)
*
|
1997-04-15 |
1999-11-11 |
Max Planck Gesellschaft |
Neue Reportervektoren für One-Hybrid und Two-Hybrid Systeme
|
AU9161998A
(en)
*
|
1997-07-29 |
1999-02-22 |
Unilever Plc |
Plasmids
|
GB2328209A
(en)
*
|
1997-08-16 |
1999-02-17 |
Stefan Andreas Oehler |
Vectors which express a coloured protein for detection of integration into a cell
|
AU2512299A
(en)
*
|
1998-01-27 |
1999-08-09 |
Novo Nordisk A/S |
Method for producing transgenic animals
|
HU230353B1
(hu)
|
1998-03-20 |
2016-02-29 |
Benitec Australia Ltd |
A génexpresszió szabályozása
|
EP1925320A3
(de)
|
1998-03-27 |
2008-09-03 |
Prolume, Ltd. |
Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
|
US7090976B2
(en)
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
AU6189599A
(en)
*
|
1998-10-15 |
2000-05-08 |
Bioimage A/S |
An improved method for extracting quantitative information relating to an influence on a cellular response
|
EP1031630B1
(de)
*
|
1999-02-22 |
2004-10-20 |
Matsushita Electric Industrial Co., Ltd. |
Verfahren zum Nachweis von Bakterien
|
US8148110B2
(en)
|
1999-03-15 |
2012-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by β-lactamase reporter fragment complementation
|
WO2001009177A2
(en)
*
|
1999-07-29 |
2001-02-08 |
Whitehead Institute For Biomedical Research |
Affinity fluorescent proteins and uses thereof
|
US6716614B1
(en)
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
CA2390011A1
(en)
*
|
1999-11-10 |
2001-05-17 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising renilla gfp
|
WO2001042786A2
(en)
|
1999-12-09 |
2001-06-14 |
Cellomics, Inc. |
System for cell based screening : cell spreading
|
KR100414641B1
(ko)
|
2000-04-07 |
2004-01-13 |
동부한농화학 주식회사 |
형질전환식물체의 생체분석방법 및 그를 이용한 시스템
|
DE60139556D1
(de)
|
2000-06-19 |
2009-09-24 |
Fisher Bioimage Aps |
Fluoreszierende proteine
|
KR100393709B1
(ko)
*
|
2000-08-07 |
2003-08-06 |
광주과학기술원 |
재조합 동물 세포주를 이용한 환경 오염 물질의 탐지 방법
|
CA2427113A1
(en)
*
|
2000-10-27 |
2002-09-12 |
Lexicon Genetics Incorporated |
Novel human 7tm proteins and polynucleotides encoding the same
|
EP1330524A2
(de)
*
|
2000-10-30 |
2003-07-30 |
Lexicon Genetics Incorporated |
Humane 7tm-proteine und dafür kodierende polynukleotiden
|
DE10136702B4
(de)
|
2000-12-27 |
2004-04-22 |
Axiogenesis Ag |
System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen
|
EP1236738A1
(de)
*
|
2001-02-23 |
2002-09-04 |
Jungbauer, Alois, Professor Dr. |
Interner Standard für ein elektrophoretisches und chromatograpgisches Trennungs-Verfahren
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
WO2002077011A2
(en)
*
|
2001-03-12 |
2002-10-03 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Oxidation-reduction sensitive green fluorescent protein variants
|
US20020188965A1
(en)
|
2001-04-20 |
2002-12-12 |
Zou-Yu Zhao |
Methods of transforming plants
|
MXPA03010967A
(es)
|
2001-05-30 |
2004-10-28 |
Chromos Molecular Systems Inc |
Cromosomas artificiales de plantas, usos de los mismos y metodos para preparar cromosomas artificiales de plantas.
|
JP3829252B2
(ja)
*
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
US6894205B2
(en)
*
|
2001-06-22 |
2005-05-17 |
Vanderbilt University |
Assay for toxin induced neuronal degeneration and viability in C. elegans
|
US7393656B2
(en)
|
2001-07-10 |
2008-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for risk stratification
|
US8048644B1
(en)
|
2001-08-01 |
2011-11-01 |
The University Of North Carolina At Charlotte |
Biological indicator for monitoring the transport of micro-organisms in the environment
|
AU2002327433A1
(en)
|
2001-08-10 |
2003-02-24 |
Cornell Research Foundation, Inc. |
Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
|
CA2472040A1
(en)
*
|
2001-12-29 |
2003-10-30 |
Woo Suk Hwang |
Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
|
US20040005301A1
(en)
*
|
2002-02-12 |
2004-01-08 |
Goldman Steven A. |
Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
US7384744B2
(en)
*
|
2002-11-29 |
2008-06-10 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
|
DE10256083A1
(de)
*
|
2002-11-29 |
2004-08-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
|
WO2004113515A2
(en)
|
2003-06-20 |
2004-12-29 |
Axiogenesis Ag |
Tissue modeling in embryonic stem (es) cell system
|
PL2308961T3
(pl)
|
2003-08-25 |
2017-08-31 |
Monsanto Technology Llc |
Elementy regulatorowe tubuliny do zastosowania w roślinach
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
US8883147B2
(en)
|
2004-10-21 |
2014-11-11 |
Xencor, Inc. |
Immunoglobulins insertions, deletions, and substitutions
|
US20060218673A9
(en)
|
2003-10-09 |
2006-09-28 |
E.I. Du Pont De Nemours And Company |
Gene silencing
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
EP1718663B1
(de)
|
2004-01-20 |
2011-07-13 |
Monsanto Technology, LLC |
Chimäre promotoren zur verwendung in pflanzen
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
CA2560334A1
(en)
|
2004-04-07 |
2005-10-20 |
Axiogenesis Ag |
Non-invasive, in vitro functional tissue assay systems
|
WO2005108598A1
(en)
|
2004-05-11 |
2005-11-17 |
Axiogenesis Ag |
Assay for drug discovery based on in vitro differentiated cells
|
US8603824B2
(en)
|
2004-07-26 |
2013-12-10 |
Pfenex, Inc. |
Process for improved protein expression by strain engineering
|
WO2006016238A2
(en)
*
|
2004-08-04 |
2006-02-16 |
Applied Research Systems Ars Holding N.V. |
Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination
|
KR101027427B1
(ko)
|
2004-11-12 |
2011-04-11 |
젠코어 인코포레이티드 |
FcRn에 대하여 증가된 결합력을 갖는 Fc 변이체
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
HUE045710T2
(hu)
|
2005-05-18 |
2020-01-28 |
Ablynx Nv |
Javított, alfa tumor nekrózis faktor elleni nanobodies
|
EP3415535B1
(de)
|
2005-05-20 |
2020-12-09 |
Ablynx N.V. |
Verbesserte nanokörper (tm) zur behandlung von aggregationsvermittelten erkrankungen
|
US8362250B2
(en)
|
2005-05-24 |
2013-01-29 |
Enzo Biochem, Inc. |
Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
|
CA2617930A1
(en)
|
2005-08-09 |
2007-03-29 |
Revivicor, Inc. |
Transgenic ungulates expressing ctla4-ig and uses thereof
|
US8859846B2
(en)
|
2005-09-21 |
2014-10-14 |
E. I. Du Pont De Nemours And Company |
Doubling of chromosomes in haploid embryos
|
ES2399563T3
(es)
|
2005-11-04 |
2013-04-02 |
Evrogen, Jsc |
Proteínas verdes fluorescentes modificadas y método para la utilización de las mismas
|
WO2007127428A2
(en)
|
2006-04-28 |
2007-11-08 |
University Of Florida Research Foundation, Inc. |
Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
|
CA2653742C
(en)
|
2006-06-06 |
2016-01-05 |
Monsanto Technology Llc |
Method for selection of plant cells transformed with a polynucleotide encoding dicamba monooxygenase using auxin-like herbicides
|
US7855326B2
(en)
|
2006-06-06 |
2010-12-21 |
Monsanto Technology Llc |
Methods for weed control using plants having dicamba-degrading enzymatic activity
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
EP3796002B1
(de)
|
2006-07-14 |
2023-11-22 |
The Regents of The University of California |
Krebsbiomarker und verfahren zur verwendung davon
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
EP2664673A3
(de)
|
2006-10-05 |
2014-02-19 |
E. I. du Pont de Nemours and Company |
microRNA-Sequenzen von Mais
|
AU2007336243B2
(en)
|
2006-12-19 |
2012-07-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
CA2673331A1
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
US7838729B2
(en)
|
2007-02-26 |
2010-11-23 |
Monsanto Technology Llc |
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
BRPI0810120A2
(pt)
|
2007-04-27 |
2014-11-11 |
Dow Global Technologies Inc |
Processo para selecionar rapidamente hospedeiros microbianos para a identificação de certas cepas com maior rendimento e/ou qualidade na expressão de proteínas heterólogas
|
SI2188313T1
(en)
|
2007-08-21 |
2018-04-30 |
Amgen, Inc. |
HUMAN C-FMS ANTIGEN TRANSFER PROTEIN
|
EP2860247A1
(de)
|
2007-08-21 |
2015-04-15 |
Nodality, Inc. |
Diagnose-, Prognose- und Behandlungsverfahren
|
US20090081715A1
(en)
*
|
2007-09-07 |
2009-03-26 |
Cobalt Technologies, Inc., A Delaware Corporation |
Engineered Light-Emitting Reporter Genes
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
EP3181228B1
(de)
|
2007-10-02 |
2020-07-29 |
Labrador Diagnostics LLC |
Modulare poc-vorrichtungen und ihre verwendung
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
EP2808343B8
(de)
|
2007-12-26 |
2020-01-15 |
Xencor, Inc. |
Fc-Varianten mit veränderter Bindung zu FcRn
|
EP2607488B1
(de)
|
2008-04-07 |
2016-11-02 |
Monsanto Technology LLC |
Pflanzliche regulatorische Elemente und deren Verwendungen
|
JP2011516520A
(ja)
|
2008-04-07 |
2011-05-26 |
アブリンクス エン.ヴェー. |
Notch経路に指向性を有するアミノ酸配列及びその使用
|
EP2268825A4
(de)
|
2008-04-09 |
2012-05-02 |
Cobalt Technologies Inc |
Immobilisierte produkttolerante mikroorganismen
|
US9250249B2
(en)
|
2008-09-08 |
2016-02-02 |
Enzo Biochem, Inc. |
Autophagy and phospholipidosis pathway assays
|
US9334281B2
(en)
*
|
2008-09-08 |
2016-05-10 |
Enzo Life Sciences, Inc. |
Fluorochromes for organelle tracing and multi-color imaging
|
US8309306B2
(en)
|
2008-11-12 |
2012-11-13 |
Nodality, Inc. |
Detection composition
|
AU2009329501B2
(en)
|
2008-12-19 |
2015-11-26 |
Ablynx N.V. |
Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
US8242248B2
(en)
|
2009-03-23 |
2012-08-14 |
Nodality, Inc. |
Kits for multiparametric phospho analysis
|
CN105399828B
(zh)
|
2009-04-10 |
2021-01-15 |
埃博灵克斯股份有限公司 |
用于治疗il-6r相关疾病和病症的改进的针对il-6r的氨基酸序列和包含其的多肽
|
EP2438087B1
(de)
|
2009-06-05 |
2017-05-10 |
Ablynx N.V. |
Trivalente anti-humanes respiratory syncytial virus (hrsv) nanobody konstrukte zur präventionund/oder behandlung von infektionen des atmungstraktes
|
WO2010151706A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Cobalt Technologies, Inc. |
Integrated system and process for bioproduct production
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
US9644022B2
(en)
|
2009-11-30 |
2017-05-09 |
Ablynx N.V. |
Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
AR079909A1
(es)
|
2010-01-14 |
2012-02-29 |
Monsanto Technology Llc |
Elementos de regulacion vegetal y sus usos
|
JP2013523184A
(ja)
|
2010-04-15 |
2013-06-17 |
アムジエン・インコーポレーテツド |
ヒトFGF受容体およびβ−KLOTHO結合性タンパク質
|
WO2011139721A1
(en)
|
2010-04-27 |
2011-11-10 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
JP6039560B2
(ja)
|
2010-08-30 |
2016-12-07 |
ダウ アグロサイエンシィズ エルエルシー |
サトウキビ桿状ウイルス(scbv)エンハンサーおよび植物機能ゲノミクスにおけるその使用
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
WO2012098260A1
(en)
|
2011-01-21 |
2012-07-26 |
Axiogenesis Ag |
A non-viral system for the generation of induced pluripotent stem (ips) cells
|
BR112013018656B1
(pt)
|
2011-01-21 |
2021-03-02 |
Labrador Diagnostics Llc |
método para detectar a presença ou concentração de um analito numa amostra de fluido contido num recipiente, e, método de medição da concentração de analito numa amostra de fluido
|
ES2666149T3
(es)
|
2011-03-25 |
2018-05-03 |
Monsanto Technology Llc |
Elementos reguladores de plantas y usos de los mismos
|
WO2012155071A1
(en)
|
2011-05-12 |
2012-11-15 |
Gilead Biologics, Inc. |
Methods of identifying lysyl oxidase - like - 2 (loxl2) binding partners
|
EA037364B1
(ru)
|
2011-05-13 |
2021-03-18 |
Монсанто Текнолоджи Ллс |
Регуляторные элементы растений и их применение
|
US9574002B2
(en)
|
2011-06-06 |
2017-02-21 |
Amgen Inc. |
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
|
US20140234330A1
(en)
|
2011-07-22 |
2014-08-21 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
US9619627B2
(en)
|
2011-09-25 |
2017-04-11 |
Theranos, Inc. |
Systems and methods for collecting and transmitting assay results
|
US8435738B2
(en)
|
2011-09-25 |
2013-05-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
US8840838B2
(en)
|
2011-09-25 |
2014-09-23 |
Theranos, Inc. |
Centrifuge configurations
|
US9268915B2
(en)
|
2011-09-25 |
2016-02-23 |
Theranos, Inc. |
Systems and methods for diagnosis or treatment
|
ES2806146T3
(es)
|
2011-09-22 |
2021-02-16 |
Amgen Inc |
Proteínas de unión al antígeno CD27L
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
EP2788384B1
(de)
|
2011-12-08 |
2017-08-09 |
Amgen Inc. |
Agonistische menschliche lcat-antigenbindende proteine und ihre verwendung in der therapie
|
WO2013130813A1
(en)
|
2012-02-29 |
2013-09-06 |
Dow Agrosciences Llc |
Sugarcane bacilliform viral (scbv) enhancer and its use in plant functional genomics
|
US9663793B2
(en)
|
2012-04-20 |
2017-05-30 |
Monsanto Technology, Llc |
Plant regulatory elements and uses thereof
|
UY34813A
(es)
|
2012-05-18 |
2013-11-29 |
Amgen Inc |
Proteínas de unión a antígeno dirigidas contra el receptor st2
|
US9040248B2
(en)
|
2012-06-06 |
2015-05-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Kits for detecting and monitoring endocrine disrupting chemicals (EDCs)
|
WO2014028939A2
(en)
|
2012-08-17 |
2014-02-20 |
California Institute Of Technology |
Targeting phosphofructokinase and its glycosylation form for cancer
|
WO2014036048A1
(en)
|
2012-08-30 |
2014-03-06 |
E. I. Du Pont De Nemours And Company |
Long intergenic non-coding rnas in maize
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Bcma抗原結合蛋白質
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
US9920121B2
(en)
|
2013-01-25 |
2018-03-20 |
Amgen Inc. |
Antibodies targeting CDH19 for melanoma
|
AU2014244444A1
(en)
|
2013-03-14 |
2015-09-24 |
Amgen Inc. |
CHRDL-1 antigen binding proteins and methods of treatment
|
WO2014140368A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza m2 and cd3
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
AU2014228924B2
(en)
|
2013-03-15 |
2019-04-18 |
Amgen Inc. |
Human PAC1 antibodies
|
EP3653642A1
(de)
|
2013-03-15 |
2020-05-20 |
Amgen Research (Munich) GmbH |
Einbettige bindemoleküle mit n-terminalen ab
|
AU2014273966B2
(en)
|
2013-05-30 |
2017-08-31 |
Kiniksa Pharmaceuticals, Ltd. |
Oncostatin M receptor antigen binding proteins
|
US10227370B2
(en)
|
2013-08-02 |
2019-03-12 |
California Institute Of Technology |
Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
|
US9770461B2
(en)
|
2013-08-02 |
2017-09-26 |
California Institute Of Technology |
Tailored glycopolymers as anticoagulant heparin mimetics
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
TWI688401B
(zh)
|
2013-09-13 |
2020-03-21 |
美商安進公司 |
用於治療骨髓性白血病的表觀遺傳因子與靶向cd33及cd3之雙特異性化合物的組合
|
JP6619745B2
(ja)
|
2014-02-20 |
2019-12-11 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
補体成分c5抗体
|
US9796776B2
(en)
|
2014-02-27 |
2017-10-24 |
Allergan, Inc. |
Complement factor Bb antibodies
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
WO2016007886A1
(en)
|
2014-07-11 |
2016-01-14 |
Northwestern University |
Yeast-based biosensor
|
UY36245A
(es)
|
2014-07-31 |
2016-01-29 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
US11661462B2
(en)
|
2014-07-31 |
2023-05-30 |
Amgen Research (Munich) Gmbh |
Optimized cross-species specific bispecific single chain antibody contructs
|
AR101400A1
(es)
|
2014-07-31 |
2016-12-14 |
Amgen Res (Munich) Gmbh |
Constructo de anticuerpo de cadena individual biespecífico con distribución mejorada de tejido
|
DE102014012130B3
(de)
|
2014-08-13 |
2015-03-05 |
Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung |
Nachweisverfahren unter Verwendung von rekombinanten lebenden Zellen zum Nachweis von xenobiotischen Stoffen sowie Anordnung und Testkit zur Durchführung des Nachweisverfahrens
|
WO2016040767A2
(en)
|
2014-09-12 |
2016-03-17 |
Amgen Inc. |
Chrdl-1 epitopes and antibodies
|
EP3227687A4
(de)
|
2014-12-05 |
2018-10-24 |
Prelude, Inc. |
Dcis-wiederauftreten und invasiver brustkrebs
|
US10654917B2
(en)
|
2015-01-29 |
2020-05-19 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
US20160264983A1
(en)
|
2015-02-04 |
2016-09-15 |
Monsanto Technology Llc |
Methods for plastid transformation
|
EP3274462A4
(de)
|
2015-03-26 |
2018-12-26 |
The Texas A&M University System |
Umwandlung von lignin in biokunststoffe und lipidbrennstoffe
|
KR20180023892A
(ko)
|
2015-04-17 |
2018-03-07 |
암젠 리서치 (뮌헨) 게엠베하 |
Cdh3 및 cd3에 대한 이중 특이성 항체 작제물
|
WO2016189118A1
(en)
|
2015-05-28 |
2016-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of prognosis and treatment of patients suffering from acute myeloid leukemia
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TW202346349A
(zh)
|
2015-07-31 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
EP3394104A2
(de)
|
2015-12-23 |
2018-10-31 |
Amgen Inc. |
Verfahren zur behandlung oder linderung von stoffwechselstörungen mit bindenden proteinen für magensäureinhibierenden peptidrezeptor (gipr) in kombination mit glp-1-agonisten
|
TWI797073B
(zh)
|
2016-01-25 |
2023-04-01 |
德商安美基研究(慕尼黑)公司 |
包含雙特異性抗體建構物之醫藥組合物
|
IL260920B
(en)
|
2016-02-03 |
2022-09-01 |
Amgen Res Munich Gmbh |
Constructs of psma and cd3 bispecific antigens that bind to t-cells, preparations containing them and uses thereof
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
EP4039709A1
(de)
|
2016-02-03 |
2022-08-10 |
Amgen Research (Munich) GmbH |
Bcma- und cd3-bispezifische t-zell-aktivierende antikörperkonstrukte
|
JOP20170091B1
(ar)
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|
KR101913163B1
(ko)
|
2016-06-30 |
2018-11-01 |
주식회사 바이오이즈 |
이중가닥 핵산 신호 프로브 및 이를 이용한 표적분자의 검출방법
|
EP3485020A1
(de)
|
2016-07-18 |
2019-05-22 |
University of Bremen |
Verfahren zur erzeugung von polyploiden pflanzen
|
JP7222888B2
(ja)
|
2016-11-16 |
2023-02-15 |
アブリンクス エン.ヴェー. |
Cd123及びtcrアルファ/ベータに結合することが可能なt細胞動員ポリペプチド
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
US11028166B2
(en)
|
2017-02-16 |
2021-06-08 |
Sonnet Bio Therapeutics |
Albumin binding domain fusion proteins
|
KR20190141243A
(ko)
|
2017-05-05 |
2019-12-23 |
암젠 인크 |
개선된 저장 및 투여를 위한 이중특이적 항체 구축물을 포함하는 약제학적 조성물
|
JOP20190259A1
(ar)
|
2017-05-31 |
2019-10-31 |
Amgen Inc |
بروتينات ربط مولد ضد مضادة لـ jagged1
|
AR111842A1
(es)
|
2017-06-02 |
2019-08-21 |
Amgen Inc |
Antagonistas de péptido pac1
|
MX2019013919A
(es)
|
2017-06-20 |
2020-01-21 |
Amgen Inc |
Metodo para tratar o mejorar trastornos metabolicos con proteinas de union para el receptor peptidico inhibidor gastrico (gipr) en combinacion con agonistas de glp-1.
|
MX2020001327A
(es)
|
2017-08-04 |
2020-03-20 |
Amgen Inc |
Metodo de conjugacion de cys-acm.
|
US20210163592A1
(en)
|
2017-12-11 |
2021-06-03 |
Amgen Inc |
Continuous manufacturing process for bispecific antibody products
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
US20200332311A1
(en)
|
2018-01-12 |
2020-10-22 |
The Texas A&M University System |
Increasing plant bioproduct yield
|
WO2019162521A1
(en)
|
2018-02-26 |
2019-08-29 |
Ablynx Nv |
Improved nucleotide sequences encoding peptide linkers
|
MA53325A
(fr)
|
2018-07-30 |
2021-06-09 |
Amgen Inc |
Administration prolongée d'une construction d'anticorps bispécifique se liant à cd33 et cd3
|
CN112512581A
(zh)
|
2018-08-03 |
2021-03-16 |
安进研发(慕尼黑)股份有限公司 |
针对cldn18.2和cd3的抗体构建体
|
EP3850368A4
(de)
|
2018-09-14 |
2022-11-23 |
Prelude Corporation |
Verfahren zur auswahl zur behandlung von subjekten mit risiko auf invasiven brustkrebs
|
TW202028239A
(zh)
|
2018-09-28 |
2020-08-01 |
美商安進公司 |
針對可溶性bcma之抗體
|
WO2020077212A1
(en)
|
2018-10-11 |
2020-04-16 |
Amgen Inc. |
Downstream processing of bispecific antibody constructs
|
JP2022512860A
(ja)
|
2018-11-06 |
2022-02-07 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
白血病幹細胞を根絶することによる急性骨髄性白血病の治療のための方法および医薬組成物
|
MA54657A
(fr)
|
2019-01-03 |
2021-11-10 |
Invetx Inc |
Compositions pour augmenter la demi-vie d'un agent thérapeutique chez les chiens et procédés d'utilisation
|
MX2021014644A
(es)
|
2019-06-13 |
2022-04-06 |
Amgen Inc |
Control de perfusion basado en biomasa automatizado en la fabricacion de productos biologicos.
|
CA3152946A1
(en)
|
2019-09-10 |
2021-03-18 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein l capture dynamic binding capacity
|
WO2021097344A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
Method for reduced aggregate formation in downstream processing of bispecific antigen-binding molecules
|
WO2021150824A1
(en)
|
2020-01-22 |
2021-07-29 |
Amgen Research (Munich) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
WO2021188851A1
(en)
|
2020-03-19 |
2021-09-23 |
Amgen Inc. |
Antibodies against mucin 17 and uses thereof
|
BR112022022922A2
(pt)
|
2020-05-11 |
2023-01-17 |
Invetx Inc |
Composições para aumentar a meia-vida de um agente terapêutico em caninos e métodos de uso
|
JP2023527293A
(ja)
|
2020-05-19 |
2023-06-28 |
アムジエン・インコーポレーテツド |
Mageb2結合構築物
|
JP2023527972A
(ja)
|
2020-05-29 |
2023-07-03 |
アムジエン・インコーポレーテツド |
Cd33及びcd3に結合する二重特異性コンストラクトの有害作用軽減投与
|
WO2022008488A1
(en)
|
2020-07-06 |
2022-01-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of slamf1 as a biomarker in colorectal cancer
|
MX2023000500A
(es)
|
2020-07-10 |
2023-04-12 |
Invetx Inc |
Composiciones para aumentar la semivida de un agente terapeutico en felinos y modos de uso.
|
WO2022013256A1
(en)
|
2020-07-15 |
2022-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of cd160 as a biomarker in acute myeloid leukemia
|
MX2023005323A
(es)
|
2020-11-06 |
2023-05-19 |
Amgen Inc |
Construcciones polipeptidicas que se unen a cd3.
|
CA3200317A1
(en)
|
2020-11-06 |
2022-05-12 |
Amgen Inc. |
Multitargeting bispecific antigen-binding molecules of increased selectivity
|
US20230406887A1
(en)
|
2020-11-06 |
2023-12-21 |
Amegen Inc. |
Antigen binding domain with reduced clipping rate
|
TW202233679A
(zh)
|
2020-11-06 |
2022-09-01 |
德商安美基研究(慕尼黑)公司 |
選擇性地與cldn6和cd3結合的多肽構建體
|
AU2022210423A1
(en)
|
2021-01-20 |
2023-07-06 |
Nautilus Subsidiary, Inc. |
Methods for biomolecule quantitation
|
TW202313681A
(zh)
|
2021-04-02 |
2023-04-01 |
美商安進公司 |
Mageb2結合構建體
|
CN117279947A
(zh)
|
2021-05-06 |
2023-12-22 |
安进研发(慕尼黑)股份有限公司 |
用于在增殖性疾病中使用的靶向cd20和cd22的抗原结合分子
|
WO2023041983A2
(en)
|
2021-09-17 |
2023-03-23 |
University Of Freiburg |
Proteins for regulation of symbiotic infection and associated regulatory elements
|
US20230143932A1
(en)
|
2021-09-20 |
2023-05-11 |
University Of Freiburg |
Pin6 proteins for the formation of nodule-like structures
|
TW202346368A
(zh)
|
2022-05-12 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
具有增加的選擇性的多鏈多靶向性雙特異性抗原結合分子
|
WO2024009146A2
(en)
|
2022-07-05 |
2024-01-11 |
University Of Freiburg |
Plant regulatory elements and uses thereof
|
US20240093220A1
(en)
|
2022-09-09 |
2024-03-21 |
Friedrich Alexander Universität Erlangen-Nürnberg |
Plant regulatory elements and uses thereof
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|